FasterCures, a center of the Milken Institute, is driven by a singular goal: to save lives by speeding up and improving the medical research system.

We focus on cutting through the roadblocks that slow medical progress by:

Why We Exist

Consider that there are approximately 10,000 known diseases affecting our world today; we have treatments for about 500 of them.

The system to discover and develop those treatments is complex, full of risk and underfunded.

That’s where FasterCures comes in.

Who We Are

As a center of the Milken Institute, with its broad base of funding from individual philanthropists, government agencies and corporate and nonprofit institutions across a diverse array of sectors and geographies, FasterCures is able to engage all stakeholders across the medical enterprise to ensure inclusion of multiple perspectives in addressing the most critical challenges in driving patient-focused medical solutions.

As a nonprofit, non-partisan think tank, we are uniquely positioned to receive input from all stakeholders and make informed, autonomous decisions when prioritizing program and project initiatives. All program objectives, publications and policy statements are developed, drafted and issued independent of sponsors.

Final project outputs are made available to all interested parties without charging access fees or membership dues.

What We Do

Patients Count: For too long, patients’ unmet medical needs have been an afterthought, rather than a starting point, for developing medical products and care that address their priorities and deliver value to the health-care system. FasterCures aims to improve health by driving adoption of methods by which patients’ perspectives shape processes for discovering, developing and delivering medical products and services.

Policy: Federal investment in research fuels promising scientific discovery and supports the development and delivery of treatments and cures. FasterCures develops and promotes science and health policy solutions to ensure that there are both sufficient resources and a supportive environment for biomedical innovation.

Collaboration 2.0: Science is increasingly complex and requires cross-sector, multi-disciplinary collaboration to make progress. FasterCures champions efficient and effective collaborations in biomedical R&D that bring together diverse partners with a shared goal.

How We Do It

Thought Leadership: From peer-reviewed journal articles to invitations for keynote speeches around the world, FasterCures’ leadership is relied upon to provide the insight and analysis diverse sectors need to navigate the medical R&D process.

Publications: FasterCures conducts unbiased, independent and analytical assessments of some of R&D's thorniest issues – from patient-centricity to intellectual property and from biomedical innovation to data sharing – and publishes results broadly, providing a roadmap for action.


  • Partnering for Cures brings together hundreds of patient advocates, researchers, investors, policymakers and more to foster the collaborations needed to speed up and improve medical R&D.
  • Hands-on workshops provide a neutral forum for leaders with diverse perspectives to examine specific R&D challenges, including building effective cross-sector partnerships (for example, between foundations and universities on the technology transfer process).
  • Capitol Hill briefings, roundtables and quarterly policy dinners increase awareness of key issues in the life sciences and engage members of Congress and their staff in efforts that can improve the medical research process.
  • Webinars spotlight innovative approaches to disease research, such as creating more effective cross-sector partnerships and addressing the patient perspective in R&D.

About the Milken Institute

The Milken Institute is a nonprofit, non-partisan think tank determined to increase global prosperity by advancing collaborative solutions that widen access to capital, create jobs and improve health.

We do this through independent, data-driven research, action-oriented meetings and meaningful policy initiatives.